Terminated PHASE4 INTERVENTIONAL 3-arm NCT00283309

Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes

Sponsor: University of Texas Southwestern Medical Center

Updated 6 times since 2017 Last updated: Apr 19, 2013 Started: Nov 30, 2005 Primary completion: Apr 30, 2007 Completion: Apr 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study finished enrollment but data was never sent for publishing.

Other terminated trials from University of Texas Southwestern Medical Center

See all terminations from University of Texas Southwestern Medical Center

A PHASE4 clinical study on Memory Deficit and Mood, this trial is terminated or withdrawn. The trial is conducted by University of Texas Southwestern Medical Center and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Texas Southwestern Medical Center

Data source: University of Texas Southwestern Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States